Live Breaking News & Updates on Greg zante

Stay informed with the latest breaking news from Greg zante on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Greg zante and stay connected to the pulse of your community

Viking Therapeutics (NASDAQ:VKTX) Shares Up 2%

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) shot up 2% on Wednesday . The company traded as high as $79.28 and last traded at $78.86. 695,202 shares were traded during mid-day trading, a decline of 89% from the average session volume of 6,382,853 shares. The stock had previously closed at $77.35. Wall Street Analyst […]

Sarah-kathryn-rouan , William-blair , Raymond-james , Greg-zante , Therapeutics-inc , Therapeutics-company-profile , Sg-americas-securities , Rafferty-asset-management , Securities-exchange-commission , Nasdaq , Citigroup-inc , Capital-partners

Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.1%

Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.1%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Greg-zante , William-blair , Vanguard-group-inc , Pricet-rowe-associates-inc , Nasdaq , Maxim-group , Securities-exchange-commission , Virtu-financial , Therapeutics-company-profile , Goldman-sachs-group-inc , Therapeutics-inc , Viking-therapeutics

Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.1%

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) dropped 4.1% on Monday . The company traded as low as $77.25 and last traded at $78.61. Approximately 1,713,032 shares were traded during trading, a decline of 74% from the average daily volume of 6,484,696 shares. The stock had previously closed at $82.00. Analysts Set […]

Greg-zante , William-blair , Virtu-financial , Therapeutics-company-profile , Therapeutics-inc , Goldman-sachs-group-inc , Vanguard-group-inc , Pricet-rowe-associates-inc , Nasdaq , Maxim-group , Securities-exchange-commission , Viking-therapeutics

Viking Therapeutics (NASDAQ:VKTX) Price Target Increased to $138.00 by Analysts at Oppenheimer

Viking Therapeutics (NASDAQ:VKTX) Price Target Increased to $138.00 by Analysts at Oppenheimer
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Stifel-nicolaus , Greg-zante , Sarah-kathryn-rouan , William-blair , Securities-exchange-commission , York-state-common-retirement-fund , Sei-investments-co , Therapeutics-company-profile , Great-west-life-assurance-co , Therapeutics-inc

BTIG Research Raises Viking Therapeutics (NASDAQ:VKTX) Price Target to $125.00

Viking Therapeutics (NASDAQ:VKTX – Free Report) had its target price lifted by BTIG Research from $100.00 to $125.00 in a research report report published on Tuesday, Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Other equities research analysts also recently issued reports about the stock. Raymond James upped their […]

Sarah-kathryn-rouan , Greg-zante , Raymond-james , William-blair , Cetera-advisor-networks , Retirement-group , Therapeutics-inc , Wetzel-investment-advisors-inc , Us-bancorp , Securities-exchange-commission , Maxim-group , Viking-therapeutics

Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 1.6%

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report)’s stock price traded down 1.6% during trading on Friday . The stock traded as low as $80.50 and last traded at $82.00. 4,331,410 shares changed hands during trading, a decline of 52% from the average session volume of 9,063,718 shares. The stock had previously closed at $83.34. […]

Sarah-kathryn-rouan , Raymond-james , Greg-zante , Jefferies-financial-group , Therapeutics-inc , Therapeutics-company-profile , Cetera-advisor-networks , Nasdaq , Us-bancorp , Wetzel-investment-advisors-inc , Retirement-group , Viking-therapeutics

Viking Therapeutics (NASDAQ:VKTX) Shares Up 4.6%

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) shot up 4.6% during trading on Monday . The stock traded as high as $73.71 and last traded at $72.76. 1,127,503 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 6,346,708 shares. The stock had previously closed at […]

Greg-zante , Stifel-nicolaus , Retirement-group , Jefferies-financial-group , Nasdaq , Maxim-group , Us-bancorp , Wetzel-investment-advisors-inc , Therapeutics-inc , Great-west-life-assurance-co , Viking-therapeutics , Get-free-report

Viking Therapeutics (NASDAQ:VKTX) Earns Buy Rating from HC Wainwright

Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports. They currently have a $90.00 target price on the biotechnology company’s stock. HC Wainwright’s price target suggests a potential upside of 6.26% from the stock’s previous close. […]

Switzerland , Swiss , William-blair , Greg-zante , Maxim-group , Dimensional-fund-advisors , Blackrock-inc , Securities-exchange-commission , York-mellon-corp , Therapeutics-inc , Jpmorgan-chase-co , Swiss-national-bank

HC Wainwright Reaffirms "Buy" Rating for Viking Therapeutics (NASDAQ:VKTX)

Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports. They presently have a $90.00 target price on the biotechnology company’s stock. HC Wainwright’s price target indicates a potential upside of 6.26% from the stock’s previous close. […]

Sarah-kathryn-rouan , Greg-zante , Raymond-james , Stifel-nicolaus , Jefferies-financial-group , Therapeutics-inc , Us-bancorp , Cetera-advisor-networks , Securities-exchange-commission , Wetzel-investment-advisors-inc , Retirement-group , Viking-therapeutics

Viking Therapeutics (NASDAQ:VKTX) PT Raised to $138.00

Viking Therapeutics (NASDAQ:VKTX – Get Free Report) had its target price raised by equities research analysts at Oppenheimer from $116.00 to $138.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has an “outperform” rating on the biotechnology company’s stock. Oppenheimer’s price target would indicate a potential upside of 65.27% from the stock’s […]

New-york , United-states , Raymond-james , William-blair , Stifel-nicolaus , Greg-zante , Therapeutics-inc , Retirement-group , Great-west-life-assurance-co , Maxim-group , Sei-investments-co , Therapeutics-company-profile